Clinical Trial Detail

NCT ID NCT03964233
Title A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 in Combination With BI 754091 and 754111
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

lung non-small cell carcinoma

melanoma

hepatocellular carcinoma

Advanced Solid Tumor

liposarcoma

Therapies

BI 754091 + BI 754111

BI 754091 + BI 754111 + BI 907828

BI 754091 + BI 907828

Age Groups: adult senior

No variant requirements are available.